prednisone has been researched along with caffeine in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (24.14) | 18.7374 |
1990's | 1 (3.45) | 18.2507 |
2000's | 14 (48.28) | 29.6817 |
2010's | 6 (20.69) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Jolivette, LJ; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Balliano, TL; Barbosa, G; Carvalho, VF; da Silva, BA; de Souza, ET; Lima, LM; Martins, IRR; Martins, MA; Medeiros, MM; Moraes Junior, MO; Nunes, IKDC; Silva, PMR; Silva, SWD | 1 |
Rölke, HW | 1 |
Levy, G | 1 |
Goenechea, S | 1 |
Ludewig, H; Ludewig, W; Poppe, G; Poppe, W | 1 |
Baba, H; Fujihara, A; Inoue, K; Isayama, T; Kanamiya, T; Maehara, Y; Ogata, K; Yoh, S; Yoshitake, K | 1 |
THURAU, H | 1 |
JAKLITSCH, H | 1 |
MIRECKI, GB | 1 |
Caldarola, G; Cozzani, E; Parodi, A; Pellicano, R | 1 |
1 review(s) available for prednisone and caffeine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 other study(ies) available for prednisone and caffeine
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Design; Enzyme Inhibitors; Humans; Hydrazones; Hypersensitivity; Lung; Male; Mice | 2020 |
[On the treatment of inflammatory and degenerative diseases of the musculosketetal system with Vertebran].
Topics: Atropine; Bone Diseases; Caffeine; Ergoloid Mesylates; Humans; Joint Diseases; Muscular Diseases; Pain; Prednisone; Pyrazoles; Strychnine | 1968 |
Effect of complex formation on drug absorption.
Topics: Amides; Animals; Antipyrine; Body Weight; Caffeine; Cyprinidae; Drug Interactions; Hydrogen-Ion Concentration; Intestinal Absorption; Kinetics; Prednisone; Propionates; Rats; Salicylamides; Secobarbital; Solubility; Surface-Active Agents; Time Factors | 1971 |
[IR demonstration of caffeine in the brain after Vertebran poisoning].
Topics: Alkaloids; Atropine; Brain Chemistry; Caffeine; Chromatography, Thin Layer; Humans; Infant; Infrared Rays; Prednisone; Pyrazoles; Spectrum Analysis; Strychnine | 1967 |
[The shy-drager syndrom, a disease of second half of life (author's transl)].
Topics: Aged; Autonomic Nervous System Diseases; Bandages; Caffeine; Dexamethasone; Erectile Dysfunction; Facial Paralysis; Female; Humans; Hypohidrosis; Hypotension, Orthostatic; Male; Middle Aged; Muscle Rigidity; Prednisone; Shy-Drager Syndrome | 1980 |
[Intra-arterial combination chemotherapy using both regimen selected by chemosensitivity test and caffeine to increase effect for osteosarcoma in extremity].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Extremities; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Osteosarcoma; Prednisone; Succinate Dehydrogenase | 1994 |
[Experiences in the treatment of bronchial asthma with Afran].
Topics: Aminopyrine; Asthma; Caffeine; Prednisone | 1962 |
[THOUGHTS ON THE CONSERVATIVE THERAPY OF VERTEBRAL SYNDROMES].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Atropine; Caffeine; Ergot Alkaloids; Humans; Intervertebral Disc Displacement; Osteochondritis; Periarthritis; Prednisolone; Prednisone; Procaine; Spinal Diseases; Spondylitis; Strychnine; Syndrome | 1964 |
[FURTHER EXPERIENCES WITH VERTEBRAN IN ORTHOPEDIC PRACTICE].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Atropine; Back Pain; Brachial Plexus Neuritis; Caffeine; Drug Therapy; Ergotamine; Humans; Hydrocortisone; Joint Diseases; Osteochondritis; Polymyalgia Rheumatica; Prednisolone; Prednisone; Procaine; Reflex Sympathetic Dystrophy; Spinal Osteophytosis; Spondylitis; Spondylitis, Ankylosing; Strychnine | 1965 |
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic.
Topics: Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Female; Glucocorticoids; Humans; Immunoglobulin A; Middle Aged; Prednisone; Skin Diseases, Vesiculobullous; Sunlight; Ultraviolet Rays | 2009 |